![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » ABBOTT, MEDINOL SETTLING PATENT SUIT AGAINST ABBOTT STENT
ABBOTT, MEDINOL SETTLING PATENT SUIT AGAINST ABBOTT STENT
July 19, 2006
Abbott Laboratories Inc. is finalizing a patent infringement case settlement with Israeli company Medinol Ltd. that could free Abbott's Xience drug-coated stent medical device from an entanglement as Abbott works to bring the product to the U.S. market.
Easy Bourse (http://www.easybourse.com/Website/dynamic/News.php?NewsID=25444&lang=fra&NewsRubrique=2)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct